News

{{ window.visitor.corporateClient.name }}

Corporate solution

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}
Welcome to our Corporate client solution

Here you can administrate your corporate solutions users.
Welcome to your subscription for Life Science Nordic
Welcome to our Corporate client solution

Your IP is registered with the company mentioned above and provides access to Life Science Nordic.

Click here to go to sign-up

Advertisement

Advertisement

EMA opens review of Europe’s first potential Lyme disease vaccine

Phase III win for LSD‑based anxiety drug

EU approves Rinvoq for severe patchy hair loss

Lilly sues six companies over black market sales of experimental weight loss drug

Low-profile Danish biotech recruits Mikael Dolsten

Advertisement

Carola Lemne: “You only know afterwards whether you made the right choice”

XVIVO’s heart technology receives CE certificates

Elicera reports strong CAR‑T-Data – shares rise

Björn Ursing: Physicians new role in AI driven healthcare

Sponsored content News from the companies

KNF Neuberger AB

100 000 timmar av beprövad tillförlitlighet: KNF:s membranpumpar sätter en ny standard

Busch Pfeiffer Vacuum AB

60 års expertis inom läcksökning: Pfeiffer Vacuum+Fab Solutions firar ett jubileum

Carl Zeiss AB

From Complex Biology to Faster Decisions: Scalable 3D HCA for NAM-Driven Drug Discovery

Aurevia

QAdvis & Scandinavian CRO are now Aurevia

Carl Zeiss AB

Experience fast and easy optical inspection

Aurevia

Strengthen your team with Clinical and Regulatory Experts

Aurevia

Clinical and regulatory expertise that delivers results

Aurevia

Medtech Compliance Forum by Aurevia & RAPS

Aurevia

Experienced clinical and regulatory support for a busy autumn

Aurevia

Expanding into the EU market?

KNF Neuberger AB

Att välja rätt material för membranpumpen

Aurevia

Flexible clinical research support for your urgent project needs

See all announcements

CF drug flops in phase II — shares collapse

Advertisement

Saniona’s neurology collaboration advances as AstronauTx Exercises acquisition option

Sobi strengthens cancer portfolio with $580m deal

CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”

Advertisement

Sprint Bioscience builds the molecules that will become new medicines

Her company is developing a new tablet form obesity drug

Advertisement

Unexpected study results on testosterone – no reduction in fracture risk

Advertisement

Advertisement

Björn Arvidsson: ”We need to change perspective”

Study: Cancer vaccine prolongs survival in difficult-to-treat tumour disease

Confidence in childhood vaccines is in decline worldwide

Advertisement

The government proposes fines for pharmaceutical companies that fail to notify drug shortages in time

Life Science-podden: The perfect moment for an IPO

Tougher competition as the Novo Nordisk Foundation broadens its programme

Advertisement

Paolo Macchiarini in court – “The sole intent was to cure”

Advertisement

Yes please, I would like to receive Life Science Nordics newsletter Read cookie and data policy.

Yes please, I would like to receive marketing, offers, surveys, etc. from Life Science Nordic Read cookie and data policy.

Advertisement Advertisement

BREAKING

{{ article.headline }}

0.349|instance-web04